T he evolution of tissue necrosis after myocardial infarction is a complex pathophysiological process that is dependent on many factors such as the duration of occlusion,' residual blood flow,2,3 and 168 Circulation Vol 86, No 1 July 1992 myocardial blood flow (MBF) and residual tissue metabolism, respectively. However, in these reports, quantification of MBF was not performed, and no attempt was made to measure the proportion of viable tissue in the regions of interest (ROIs) defined.
In this study, PET imaging was used to measure absolute MBF and to investigate the use of a quantitative parameter of tissue viability, the water-perfusable tissue index (PTI). This is obtained from the analysis of transmission, blood volume (15O-carbon monoxide: C150), and MBF (`50-water: H2150) emission data sets. This procedure has the potential advantages that, first, both MBF and tissue viability can be assessed simultaneously using the same tracer and, second, that the need for metabolic imaging may be obviated. To investigate whether this new strategy was accurate in assessing myocardial viability, these measurements were made in three groups of subjects: normal volunteers, patients with old myocardial infarction (OMI), and patients with acute myocardial infarction (AMI) after successful thrombolysis. In the AMI patients, cardiac function was assessed by echocardiography and improvement of contractile function was considered as evidence of tissue viability. In the OMI group, we compared PTI with 18FDG metabolic imaging for detecting tissue viability, as coronary revascularization in these patients was not performed. Theory
Recently, a method for calculation of MBF using C1502 inhalation and dynamic PET has been reported.11
Briefly, time-activity curves generated from ROIs placed over the left atrial chamber and left ventricular myocardium were fitted to a single tissue compartment model that is described by Equation 1 : CROI(t)= a-MBF* Ca(t)O)exp[-(MBF/p+A) * t]+Va * Ca(t) (1) where CROI(t) equals H2150 concentration in the tissue ROI (counts/sec/ml of ROI); a equals tissue fraction (g of H2150-perfusable tissue/ml of ROI); MBF equals regional myocardial blood flow to the H2150-perfusable tissue (ml/min/g of H2150-perfusable tissue); Ca(t) equals H215O concentration in the arterial ROI (counts/ sec/ml of ROI); 0 is the symbol for the operation of convolution; p is the partition coefficient of water (ml of blood/g of tissue); A is the decay constant of 'SO; and Va equals the fraction of arterial blood in the tissue plus spillover from left ventricle (ml of arterial blood/ml of ROI).
This operational equation incorporates two corrections. First, the spillover of activity from the left ventricular chamber into the myocardial ROI because of the limited spatial resolution of the PET scanner was accounted for by the term Va. Second, the underestimation of myocardial radiotracer concentration caused by cardiac wall motion and the small transmural myocardial thickness relative to the spatial resolution of PET scanners (the so-called partial volume effect), was corrected for by implementation of the concept of tissue fraction (a), as first proposed by lida et al. 12 These workers defined tissue fraction as the fractional volume of a given ROI occupied by myocardium that is capable of rapidly exchanging water, i.e., the H215O-perfusable (blood density) from the transmission data after normalization of the latter to tissue density. ATF contains both perfusable and nonperfusable tissue components. who arrived in the emergency room within 4 hours of onset of severe continuing chest pain. The clinical diagnosis of AMI was made on the basis of typical chest pain and ECG changes. All patients developed significant Q waves (>0.04 seconds) and a rise in cardiac enzymes. After AMI was diagnosed, subjects underwent emergency catheterization according to a protocol approved by the Hammersmith Hospital Research Ethics Committee. Intracoronary administration of streptokinase or tissue plasminogen activator (tPA) recanalized the infarct-related artery in eight of 11 subjects (A2-A8 and All). In two of the three remaining patients (A9, A10), spontaneous recanalization had occurred at the time of the acute-phase angiogram, but thrombolytic agent was still administered because of the very slow washout of contrast medium from the infarctrelated artery. The last patient (A1) underwent spontaneous recanalization after administration of thrombolytic agents failed to achieve vessel patency. In all subjects, follow-up angiograms confirmed successful recanalization of the infarct-related artery 24 hours later.
In all patients, wall motion abnormalities in the risk areas were revealed by two-dimensional echocardiography, which was performed on the same day as the PET scan. In the subacute phase, PET scanning was performed within 4 Venous blood samples were taken every minute during the scan, and the C1"0 concentration in whole blood was measured using a Nal well counter cross-calibrated with the scanner.
After a 15-minute period to allow for decay of 150 radioactivity to background levels, MBF was measured using a previously validated protocol." Briefly, C1502 gas, which is converted in the lung to "50-labeled water (H2,50) was inhaled for a period of 3.5 minutes (4 MBq/ml at a flow rate of 500 ml/min). A A blood volume image (VB) was calculated using the C"50 emission data. The raw image was divided by the product of the average of the blood radioactivity concentration (counts/sec/g of whole blood) measured from the venous blood samples and the density of whole blood (1.06 g/ml). These images were also corrected to account for the decay of`50 during the 6-minute acquisition period. The resultant quantitative images of blood volume have units of milliliters of blood per image volume element. These images were used to position two to four ROls in the left atrial chamber with a recovery greater than 90% of the true tracer concentration. These ROTs were then projected onto the dynamic "50-water data set to generate time-activity curves for each ROI. The average of these curves was used as arterial input function for calculation of MBF.1 Images of extravascular tissue density were created by subtracting images of blood density (VBX 1.06) from the corresponding transmission images after conversion of the latter to tissue density (1.06 xtransmission/counts on transmission image from a left ventricular ROI). This method has been described and validated previously for the lung'3 and more recently for the heart.'4'16"17 Myocardial tissue ROTs with an average size of 2.8±0.8 cm' were positioned in four myocardial segments (anterior, lateral, inferior, and septal) on these transaxial images as illustrated in Figure 2 . Values of ATF (see "Theory" and Figure 1 ) for each tissue ROI were determined from these images and have units of grams of total anatomical tissue per milliliter of ROI.
To ensure that minimal patient movement had occurred during the study, the position of these tissue Figure 1 ). Consequently, PTI for each myocardial region was calculated by taking the ratio of PTF/ATF. The PET images used for this analysis are illustrated in Figure 3 .
The tissue ROTs described above were also projected onto the`8FDG images, and in each individual, the mean pixel counts for all segments supplied by normal uninvolved coronary arteries and normal wall motion were calculated. In each subject, the`8FDG pixel counts in the tissue ROIs positioned in the asynergic regions were expressed as a proportion of the counts in the corresponding control regions, thus providing a relative value of`8FDG uptake in the infarcted zone. The`8FDG data were normalized to blood flow according to previously reported criteria.'8 The relative`8FDG uptake in the asynergic regions was normalized to the relative defect in MBFp as follows. Metabolism-flow ratio= (FDG counts in asynergic zone/ FDG counts in control region) (2) 0.53+±0.12 g (perfusable tissue)/g (total anatomical tissue). These data are illustrated in Figure 6 . No significant differences were found in the values of Va, ATF, and MBFt (Table 2) . AMI Patients (Group 3) In the subacute phase, systolic wall thickening was severely reduced in 12 myocardial regions after thrombolytic therapy. The anatomical site of these asynergic segments correlated in all cases with the region supplied by the infarct-related artery. On the follow-up echocardiograms, seven of these segments had improved systolic wall thickening. These were defined as the recovery segments. Systolic wall thickening in the recovery regions was still lower than in the remote control segments but not to a statistically significant extent (p=NS).
The angiographic profiles of these patients are summarized in Table 3 . There were no differences between the degree of stenosis or the interval from onset of AMI to recanalization between the recovery and nonrecovery segments.
The PET data for this group of patients are summarized in Table 4 . Analysis of the data acquired in the subacute phase by ANOVA showed that there were significant differences in the values of MBFp (p=0.02), PTF (p<0.001), and PTI (p<0.001) (Figure 7) between the recovery, nonrecovery, and remote control regions.
MBFp in both the recovery and nonrecovery segments were both reduced relative to their respective remote control segments (p=0.009 andp=0.004, respectively).
However, MBFp in the recovery and nonrecovery regions was similar at this time ( Figure 7) . The difference in PTI between groups was solely attributable to the values of this parameter being significantly lower in the nonrecovery group relative to the recovery and remote control segments. PTI in the recovery and remote control segments were not significantly different (Figure 7) .
Repeat PET In normal myocardium, we hypothesized that the value of PTI should be unity, as all the myocardium should have been perfusable by H2150. This was found to be the case in all (apart from septal) myocardial segments in normal volunteers and in the remote control segments in both patient groups. In the septum, PTI was significantly higher than in the other left ventricular ROIs resulting from the spillover of activity from the right ventricular chamber into septal tissue ROls caused by the limited spatial resolution of the PET scanner. The concentration of H2150 in the right ventricular chamber is equivalent to that in venous blood, which is the same as in tissue, as H2150 is a freely diffusible tracer. Therefore, the spillover from the right ventricular chamber is considered by the model as an additional tissue component, hence, the overestimation of PTF.
AMI Patients
We found that in successfully thrombolysed AMI patients (group 3), systolic wall thickening improved in seven of 12 affected segments. In the subacute phase, PTI in the recovery segments was well preserved and not significantly different from the remote control segments. We performed an additional '8FDG scan in two of these patients and observed a positive uptake. In the nonrecovery regions, PTI was significantly decreased compared with the recovery segments and was similar to that found in segments without '8FDG uptake in the OMI patients. PTI for a given ROI was defined as the fraction of the anatomical tissue that was perfusable by H21'0. Our data indicate that only those segments with a preserved PTI (i.e., >0.7) recovered contractile function. We performed repeat PET scans on six of the 11 patients at the time of the follow-up echocardiography and showed that in the recovery segments, PTI was similar to that measured in the subacute phase. In the recovery regions, PTI was lower than in the control segments, but this did not reach statistical significance. This suggests the presence of some tissue damage in these regions as a result of the acute ischemic insult. No improvement in PTI was observed in segments in which contractile function remained depressed. These data suggest that at least 70% of the myocardium should be perfusable by water to enable improvement of contractile function.
In the subacute phase, MBFp was reduced to a similar extent in both the recovery and the nonrecovery segments relative to the remote control segments. The diminished values of MBFp in the recovery segments in the subacute phase can be explained by the decreased myocardial metabolic demand as a result of the reduced wall thickening at this time. However, MBFp was not a good predictor of recovery of myocardial contractile function, as there was no significant difference between the values in the recovery and the nonrecovery segments. At follow-up, MBFp in the recovery segments was greater than at the subacute phase because of the improvement in myocardial contractility. In the nonrecovery segments, no increase in MBFp was observed.
Comparison With`8FDG
The presence of residual metabolism in infarcted segments has been documented previously by Tillisch dial infarction. This study showed that in asynergic regions that had both a relatively reduced blood flow and a relatively preserved or enhanced`8FDG uptake ("mismatch"), revascularization improved contractile function. These workers also showed that in regions that were both hypoperfused and had a depressed '8FDG uptake ("match"), revascularization did not improve the regional wall motion abnormality. These data provided the basis for the terms "PET viable" and "PET necrotic." Similar findings were subsequently reported in patients after AMI.9
Of the 15 subjects with OMI (group 2) investigated in the present study, nine patients had asynergic regions in which the metabolism-flow ratio was >1.20, whereas in the remaining six patients, this ratio was found to be < 1.20. The threshold value of 1.20 for the metabolismflow ratio has recently been suggested to distinguish reversibly from irreversibly injured tissue.18 This approach is similar to the original methods used for assessing myocardial viability from metabolism and perfusion PET images.8-10 There was no significant difference in the values of MBFp between the reversibly and irreversibly injured tissue defined above. These findings further demonstrate the inadequacy of perfusion measurement alone to discriminate viable from nonviable myocardium. This distinction was detected by measurement of PTI, which was significantly higher in asynergic regions that were deemed reversibly injured on the basis of having metabolism-flow ratios 21.20 .
Although recent studies have demonstrated the presence of 18FDG uptake in reperfused myocardium showing a wide degree of histologically defined transmural necrosis,2324 there is considerable evidence that preserved`8FDG uptake augurs an improvement in contractile function upon successful reperfusion.9 10, [25] [26] [27] [28] In our study, there was agreement between the PTI data and the metabolism-flow ratio for identifying reversibly from irreversibly injured myocardium. Ideally, a direct comparison of '8FDG uptake, PTI, and wall motion recovery should have been performed. However, this was not performed in the interest of minimizing the scanning duration for patients in an unstable condition. In the two AMI patients in whom we were able to perform metabolic imaging, concordance was observed between PTI,`8FDG uptake, and improvement in systolic function.
PTI In the AMI patients, PTI has an apparent 100% sensitivity in distinguishing recoverable and irreversibly damaged tissue. Although these findings should be confirmed in a larger study group, this represents a particularly attractive feature of using PTI for assessing myocardial viability. Indeed, an identical threshold value of PTI for predicting improved regional wall motion after coronary revascularization has also been observed.30 To our knowledge, systematic studies designed specifically to assess the degree of transmural histologically defined necrosis that limits improvement in regional wall motion after revascularization have not been performed. Previous studies have investigated the degree of transmural necrosis that correlates with the severity of wall motion abnormalities identified by using a number of techniques.31-33 These studies indicated a direct relation between the extent of transmural necrosis and the severity of the wall motion abnormality. In one study,33 a weak but statistically significant correlation between the severity of the preoperative wall motion abnormality and subsequent postrevascularization improvement in regional wall motion was observed. Thus, although a relation between the degree of transmural myocardial necrosis and postreperfusion improvement in myocardial contractility can be surmized, the precise details of this relation remain to be elucidated.
There are several practical advantages to this method of assessing tissue viability. First, the entire study can be performed in less than 1 hour. This decreases the chance of patient movement occurring during the study and has the logistical advantage of increasing patient throughput. Second, the lack of requirement for`8FDG in this method decreases the total scanning duration, the radiation dose to the patient, and the cost of the procedure. The advent of relatively inexpensive equipment dedicated to the production of tracers labeled with 5O should make this method more amenable to clinical centers.
Conclusions
In summary, we have evaluated a new parameter, PTI, for assessing myocardial viability by performing studies in OMI patients and AMI patients after the administration of thrombolytic agents. In the latter group, improvement in cardiac wall motion was used as evidence of myocardial viability. However, in the OMI patients, the previously reported 18FDG method was used as evidence of tissue viability, as revascularization was not performed.
We have shown that in the OMI patients, PTI in infarcted segments considered viable (on the basis of the preserved 18FDG uptake relative to the level of myocardial perfusion) was significantly higher than in those segments in which there was a concomitant reduction of both '8FDG uptake and perfusion. In the group of patients who were successfully thrombolysed after AMI, we showed that contractile recovery only occurred in segments in which PTI was >0.7. These data suggest that at least 70% of the tissue within a given ROI should be perfusable by water to enable improvement of contractile function. Although further studies in experimental animals and in a larger group of patients would be required to confirm our initial findings, these data suggest that PTI is a good prognostic indicator of improvement in contractile function, and that myocar- 
